Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma — Antonio Palumbo (2007) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma
Shared by
Meletios A Dimopoulos
Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma
Article
2007
en
Authors
+31 more
AP
Antonio Palumbo
SR
S. Vincent Rajkumar
Meletios A Dimopoulos
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2007
How to prevent deep vein thrombosis in myeloma patients receiving thalidomide or lenalidomide
Efstathios Kastritis
,
Meletios A Dimopoulos
Article
2007
Thalidomide in the treatment of multiple myeloma
Efstathios Kastritis
,
Meletios A Dimopoulos
Letter
2018
Thalidomide for myeloma: still here?
Meletios A Dimopoulos
,
Efstathios Kastritis
Article
2006
Comparison of lenalidomide in combination with dexamethasone to dexamethasone alone in patients who have received prior thalidomide in relapsed or refractory multiple myeloma
M. Wang
,
Robert Knight
,
Meletios A Dimopoulos
,
David S. Siegel
,
S. Vincent Rajkumar
,
Thierry Façon
,
Zhinuan Yu
,
J. Zeldis
,
Marta Olesnyckyj
,
D. Weber
Article
2008
Lenalidomide plus dexamethasone is more effective than dexamethasone alone in patients with relapsed or refractory multiple myeloma regardless of prior thalidomide exposure
Michael Wang
,
Meletios A Dimopoulos
,
Christine Chen
,
María Teresa Cibeira
,
Michel Attal
,
Andrew Spencer
,
S. Vincent Rajkumar
,
Zhinuan Yu
,
Marta Olesnyckyj
,
Jerome B. Zeldis
,
Robert Knight
,
Donna M. Weber
Discussion(0)
No comments yet. Be the first to comment.